Every time I see a VC job posting asking for a PE or IB background, I get chills.
They should create a new label for VC and PE bc they are completely different jobs.
Been experimenting with GPT models for dealflow automation — screening, labeling, and sourcing.
Built a beta tool and looking to connect with others in VC or data-driven investing exploring similar ideas.
My first successful trade… lol kidding.
But definitely my first sentimental trade — and I got 5x.
I love Spotify, but I haven’t seen any new products or AI implementation.
Have you?
The second episode of Pills of Medtech & Medicine featured discussions on #cardiology and #sports#medicine with guest speakers interventional cardiologist @TaorminaAntoni1 and the doctor of the Italian female volleyball national team Domenico Capodiferro
@freedomstreetradio
78yo gentleman with PVC burden of 23k, highly symptomatic. Careful mapping of the RV showed earliest site at the basal septum, close enough (8.8mm) from His/RB. Stability achieved with @Stereotaxis, solid lesion with no lead gowns. Enjoyed EGMs and the not usual site of origin.
@darrenmarble Agree 100%.. new generation of founders bases on facts/evidence and not on fake hopes and promises like in the past. Is it a pattern you noticed?
My boyfriend replied to me:
“You know the rule of 100, 10 and 1?
I can meet 100 girls, maybe have a relationship with 10 of them.
But only one of them will be the right one 🧡”
@tunneleffext
Do you know the 𝟭𝟬𝟬, 𝟭𝟬, 𝗮𝗻𝗱 𝟭 𝗿𝘂𝗹𝗲?
.........If you want to be a seed financier you have to screen one hundred projects, you can finance only ten, and only one will be successful.........
what do you think?
#VC#healthcare#medtech#startups#innovation
EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization
TAM: Total Addressable Market
LTV: Lifetime Value
CAC: Customer Acquisition Cost
MVP: Minimum Viable Product
KPI: Key Performance Indicator
SaaS: Software as a Service
B2B: Business-to-Business
📔𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐄𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭: Biotech benefits from a well-established regulatory environment, providing investor confidence in drug approvals and commercialization